tradingkey.logo

Mirion Technologies Inc

MIR
24.070USD
+0.860+3.71%
Close 02/06, 16:00ETQuotes delayed by 15 min
5.80BMarket Cap
189.75P/E TTM

Mirion Technologies Inc

24.070
+0.860+3.71%

More Details of Mirion Technologies Inc Company

Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis, and monitoring solutions to the medical, nuclear, defense, and research end markets. The Company's segments include Nuclear & Safety and Medical. The Medical includes products and services for radiation therapy, nuclear medicine and personal dosimetry. This segment’s principal product offering is Radiation Therapy Quality Assurance, which includes solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy. The Nuclear & Safety includes products and services focused on addressing critical radiation safety, measurement and analysis applications across nuclear energy, laboratories and research and other industrial markets such as defense. For Nuclear Power Plants (NPPs), it sells products and services for use at any stage of their life (construction, operation, decommissioning and dismantling).

Mirion Technologies Inc Info

Ticker SymbolMIR
Company nameMirion Technologies Inc
IPO dateJun 29, 2020
CEOLogan (Thomas D)
Number of employees2860
Security typeOrdinary Share
Fiscal year-endJun 29
Address1218 Menlo Drive
CityATLANTA
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code30318
Phone17704322744
Websitehttps://www.mirion.com/
Ticker SymbolMIR
IPO dateJun 29, 2020
CEOLogan (Thomas D)

Company Executives of Mirion Technologies Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Director
Independent Director
4.76M
+806.00%
Mr. Brian Schopfer
Mr. Brian Schopfer
Chief Financial Officer
Chief Financial Officer
742.63K
-11000.00%
Mr. Loic Eloy
Mr. Loic Eloy
Group President - Nuclear and Safety
Group President - Nuclear and Safety
78.83K
-45000.00%
Mr. John W. Kuo, J.D.
Mr. John W. Kuo, J.D.
Independent Director
Independent Director
69.36K
-4860.00%
Mr. Kenneth C. Bockhorst
Mr. Kenneth C. Bockhorst
Lead Independent Director
Lead Independent Director
66.50K
-9680.00%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
50.04K
+7977.00%
Ms. Emmanuelle Lee
Ms. Emmanuelle Lee
Chief Legal Officer, Chief Compliance Office, Deputy General Counsel
Chief Legal Officer, Chief Compliance Office, Deputy General Counsel
37.02K
-5913.00%
Mrs. Alison Ulrich
Mrs. Alison Ulrich
Chief Human Resources Officer
Chief Human Resources Officer
16.15K
-134.00%
Mr. Thomas D. Logan
Mr. Thomas D. Logan
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Steven W. (Steve) Etzel
Mr. Steven W. (Steve) Etzel
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Director
Independent Director
4.76M
+806.00%
Mr. Brian Schopfer
Mr. Brian Schopfer
Chief Financial Officer
Chief Financial Officer
742.63K
-11000.00%
Mr. Loic Eloy
Mr. Loic Eloy
Group President - Nuclear and Safety
Group President - Nuclear and Safety
78.83K
-45000.00%
Mr. John W. Kuo, J.D.
Mr. John W. Kuo, J.D.
Independent Director
Independent Director
69.36K
-4860.00%
Mr. Kenneth C. Bockhorst
Mr. Kenneth C. Bockhorst
Lead Independent Director
Lead Independent Director
66.50K
-9680.00%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
50.04K
+7977.00%

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
By BusinessUSD
Name
Revenue
Proportion
Nuclear
81.80M
36.67%
Cancer care
62.00M
27.79%
Labs and research
34.00M
15.24%
Nuclear and safety-Other
28.80M
12.91%
Medical-Other
16.50M
7.40%
By RegionUSD
Name
Revenue
Proportion
Northern America
144.20M
64.63%
Europe
75.70M
33.93%
Asia Pacific
3.20M
1.43%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Nuclear
81.80M
36.67%
Cancer care
62.00M
27.79%
Labs and research
34.00M
15.24%
Nuclear and safety-Other
28.80M
12.91%
Medical-Other
16.50M
7.40%

Shareholding Stats

Updated: Fri, Jan 23
Updated: Fri, Jan 23
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.13%
The Vanguard Group, Inc.
12.22%
T. Rowe Price Investment Management, Inc.
8.70%
Kuwait Investment Authority
4.10%
State Street Investment Management (US)
3.56%
Other
58.29%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.13%
The Vanguard Group, Inc.
12.22%
T. Rowe Price Investment Management, Inc.
8.70%
Kuwait Investment Authority
4.10%
State Street Investment Management (US)
3.56%
Other
58.29%
Shareholder Types
Shareholders
Proportion
Investment Advisor
59.04%
Investment Advisor/Hedge Fund
33.03%
Hedge Fund
7.71%
Sovereign Wealth Fund
4.18%
Individual Investor
3.70%
Family Office
3.54%
Research Firm
2.16%
Pension Fund
1.06%
Bank and Trust
0.84%

Institutional Shareholding

Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
643
257.19M
103.78%
+16.79M
2025Q3
568
218.98M
88.36%
+5.81M
2025Q2
482
202.24M
88.76%
-16.70M
2025Q1
461
196.77M
87.24%
-13.76M
2024Q4
413
201.38M
89.23%
-34.17M
2024Q3
364
208.86M
92.88%
-24.70M
2024Q2
347
200.91M
91.31%
-22.95M
2024Q1
340
192.50M
88.03%
-24.17M
2023Q4
330
191.09M
87.68%
-28.19M
2023Q3
353
191.03M
87.66%
-36.72M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
32.53M
13.13%
+18.49M
+131.76%
Sep 30, 2025
The Vanguard Group, Inc.
30.37M
12.25%
+6.65M
+28.05%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
21.57M
8.7%
+609.12K
+2.91%
Sep 30, 2025
State Street Investment Management (US)
8.82M
3.56%
+3.72M
+73.07%
Sep 30, 2025
Omega Advisors, Inc.
8.38M
3.38%
+1.26M
+17.66%
Sep 30, 2025
Fidelity Management & Research Company LLC
8.08M
3.26%
+7.13M
+753.26%
Sep 30, 2025
Janus Henderson Investors
7.66M
3.09%
-326.46K
-4.09%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
6.21M
2.5%
-740.45K
-10.66%
Sep 30, 2025
Geode Capital Management, L.L.C.
5.63M
2.27%
+889.67K
+18.77%
Sep 30, 2025
View more

Related ETFs

Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
TCW Transform Systems ETF
6.65%
Gabelli Love Our Planet & People ETF
5.64%
Invesco S&P SmallCap Information Technology ETF
3.27%
Alpha Architect U.S. Quantitative Momentum ETF
1.78%
State Street SPDR S&P Kensho Future Security ETF
1.44%
Invesco S&P SmallCap 600 Pure Growth ETF
1.36%
Range Nuclear Renaissance Index ETF
1.26%
State Street SPDR S&P 600 Small Cap Growth ETF
0.99%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.93%
iShares S&P Small-Cap 600 Growth ETF
0.91%
View more
TCW Transform Systems ETF
Proportion6.65%
Gabelli Love Our Planet & People ETF
Proportion5.64%
Invesco S&P SmallCap Information Technology ETF
Proportion3.27%
Alpha Architect U.S. Quantitative Momentum ETF
Proportion1.78%
State Street SPDR S&P Kensho Future Security ETF
Proportion1.44%
Invesco S&P SmallCap 600 Pure Growth ETF
Proportion1.36%
Range Nuclear Renaissance Index ETF
Proportion1.26%
State Street SPDR S&P 600 Small Cap Growth ETF
Proportion0.99%
Vanguard S&P Small-Cap 600 Growth Index Fund
Proportion0.93%
iShares S&P Small-Cap 600 Growth ETF
Proportion0.91%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI